These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 28990243)
1. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer. Zhou Q; Huang SX; Zhang F; Li SJ; Liu C; Xi YY; Wang L; Wang X; He QQ; Sun CC; Li DJ Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990243 [TBL] [Abstract][Full Text] [Related]
2. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer. Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956 [TBL] [Abstract][Full Text] [Related]
3. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Zhang Y; Zhang Y; Yin Y; Li S Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Tumor-Derived Exosomal miRNA as Potential Diagnostic Biomarkers for Early-Stage Non-Small Cell Lung Cancer Using Next-Generation Sequencing. Jin X; Chen Y; Chen H; Fei S; Chen D; Cai X; Liu L; Lin B; Su H; Zhao L; Su M; Pan H; Shen L; Xie D; Xie C Clin Cancer Res; 2017 Sep; 23(17):5311-5319. PubMed ID: 28606918 [No Abstract] [Full Text] [Related]
5. Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer. Xia J; Luo M; Dai L; Wang L; Wang L; Zhu J J Clin Lab Anal; 2021 May; 35(5):e23743. PubMed ID: 33682961 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of Exosomal miRNA in Blood as a Potential Diagnostic Biomarker for Human Non-Small Cell Lung Cancer. Xu Z; Wang Z; Sun H; Xin H Med Sci Monit; 2020 May; 26():e924721. PubMed ID: 32444593 [TBL] [Abstract][Full Text] [Related]
7. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218 [TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies. Chen L; Jin H Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397 [TBL] [Abstract][Full Text] [Related]
9. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer. Wang K; Chen M; Wu W World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412 [TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of microRNA expression profiling in non small cell lung cancer. Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108 [TBL] [Abstract][Full Text] [Related]
11. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma. Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597 [TBL] [Abstract][Full Text] [Related]
12. Circulating miRNA-21 and miRNA-23a Expression Signature as Potential Biomarkers for Early Detection of Non-Small-Cell Lung Cancer. Hetta HF; Zahran AM; Shafik EA; El-Mahdy RI; Mohamed NA; Nabil EE; Esmaeel HM; Alkady OA; Elkady A; Mohareb DA; Hosni A; Mostafa MM; Elkady A Microrna; 2019; 8(3):206-215. PubMed ID: 30652656 [TBL] [Abstract][Full Text] [Related]
13. Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer. Jiang LP; Zhu ZT; He CY Future Oncol; 2016 May; 12(9):1105-15. PubMed ID: 27033050 [TBL] [Abstract][Full Text] [Related]
14. Potential circulating miRNA signature for early detection of NSCLC. Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589 [TBL] [Abstract][Full Text] [Related]
15. Exosomal miRNAs as biomarkers for diagnostic and prognostic in lung cancer. Wu J; Shen Z Cancer Med; 2020 Oct; 9(19):6909-6922. PubMed ID: 32779402 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of Plasma Exosomal MicroRNA-451a as a Noninvasive Biomarker for Early Prediction of Recurrence and Prognosis of Non-Small Cell Lung Cancer. Kanaoka R; Iinuma H; Dejima H; Sakai T; Uehara H; Matsutani N; Kawamura M Oncology; 2018; 94(5):311-323. PubMed ID: 29533963 [TBL] [Abstract][Full Text] [Related]
17. Plasma miRNAs in predicting radiosensitivity in non-small cell lung cancer. Chen X; Xu Y; Liao X; Liao R; Zhang L; Niu K; Li T; Li D; Chen Z; Duan Y; Sun J Tumour Biol; 2016 Sep; 37(9):11927-11936. PubMed ID: 27075472 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCs. Du L; Schageman JJ; Irnov ; Girard L; Hammond SM; Minna JD; Gazdar AF; Pertsemlidis A J Exp Clin Cancer Res; 2010 Jun; 29(1):75. PubMed ID: 20624269 [TBL] [Abstract][Full Text] [Related]
19. Prospects of microRNAs as therapeutic biomarkers in non-small cell lung cancer. Samson JS; Parvathi VD Med Oncol; 2023 Nov; 40(12):345. PubMed ID: 37922117 [TBL] [Abstract][Full Text] [Related]
20. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Markou A; Liang Y; Lianidou E Clin Chem Lab Med; 2011 Oct; 49(10):1591-603. PubMed ID: 21767219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]